NCT05257486View on ClinicalTrials.gov

Post-market Multi-Center RETRO-Prospective Study to Assess Long-term Clinical Outcomes NMSC Patients Treated With eBx

CompletedOBSERVATIONAL

Enrollment

183

Participants

Timeline

Start Date

March 9, 2022

Primary Completion Date

July 18, 2022

Study Completion Date

October 13, 2022

Conditions

Non-melanoma Skin Cancer

Interventions

DEVICE

Xoft eBx

The Xoft Axxent Electronic Brachytherapy (eBx) System allows for the administration of high dose rate brachytherapy treatments using an electronic source

Trial Locations (2)

91910

Dermatology & Laser Center of San Diego, San Diego

95032

Kenneth A. Miller, MD Dermatology, Campbell

All Listed Sponsors

lead

Xoft, Inc.

INDUSTRY